Novo Nordisk split puts Hims & Hers future in question
Yahoo Financearrow_outwardHims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future
Los Angeles Timesarrow_outwardACLU Files Class Action To Bypass Supreme Court Decision on Birthright Citizenship
The New York Sunarrow_outwardNovo Nordisk (NVO) Terminates Hims & Hers Partnership Over Wegovy Sales Issues - Insider Monkey
Insider Monkeyarrow_outwardNew weight-loss drug Wegovy is here, but is it a magical solution? Experts weigh in - Hindustan Times
Hindustan Timesarrow_outwardHims & Hers Faces Legal Storm Over Wegovy Claims - TipRanks
TipRanksarrow_outwardHims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover? - The Motley Fool
The Motley Foolarrow_outwardHims & Hers Face Investor Suits Over Wegovy Collab - Law360
Law360arrow_outwardNovo Nordisk and WeightWatchers Partnership, Plus $299 Wegovy Offer - Managed Healthcare Executive
Managed Healthcare Executivearrow_outwardNovo Nordisk inks partnership with WeightWatchers to broaden Wegovy access - Fierce Healthcare
Fierce Healthcarearrow_outwardNovo Nordisk ends Hims & Hers deal over Wegovy knockoffs - NJBIZ
NJBIZarrow_outwardNovo Nordisk rebounds with WeightWatchers days after Hims & Hers Health breakup over compounded Wegovy - FirstWord Pharma
FirstWord Pharmaarrow_outwardNovo Nordisk says WeightWatchers will sell Wegovy, announces $299 price - StreetInsider
StreetInsiderarrow_outwardNovo Nordisk to Expand Access to Wegovy With WeightWatchers Partnership - WSJ
WSJarrow_outwardWeightWatchers Customers Now Have Access to Wegovy at a Cheaper Price - Bloomberg
Bloombergarrow_outwardNovo Nordisk partners with WeightWatchers to expand Wegovy access - Investing.com
Investing.comarrow_outwardNovo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety - PR Newswire
PR Newswirearrow_outwardWegovy Now Available Through WeightWatchers at $299: Novo Nordisk Expands Official Distribution Network - Stock Titan
Stock Titanarrow_outwardLilly to launch Mounjaro pen in India to compete with Novo's Wegovy - Yahoo
Yahooarrow_outwardCan 2 blockbuster weight loss injectables, Wegovy & Mounjaro, fight India’s obesity curve? Listen in to the experts - The Indian Express
The Indian Expressarrow_outwardWeight-loss jabs linked to hundreds of cases of life-threatening illness and 10 deaths - the-independent.com
The-independent.comarrow_outwardNew data show most patients now stay on Wegovy, Zepbound after a year - Reuters
Reutersarrow_outwardNovo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20% - MSN
MSNarrow_outwardHims & Hers CEO hits Novo Nordisk after breakup over knockoff Wegovy - Quartz
Quartzarrow_outwardBattle For Obesity Market Shifts Gears in India: Will Wegovy Trump Mounjaro? - insights.citeline.com
Insights.citeline.comarrow_outwardWegovy enters India: Experts discuss health impact of the popular weight loss drug - Times of India
Times of Indiaarrow_outwardWeight-loss drug Wegovy starts at ₹17,345 in India - The Economic Times
The Economic Timesarrow_outwardNovo Nordisk accuses telehealth company Hims of 'deceptive marketing' and ends Wegovy partnership - Scripps News
Scripps Newsarrow_outwardWhat Ozempic and Wegovy are really doing to your mouth - The Independent
The Independentarrow_outwardLilly’s Antibody Protects Patients From Losing Muscle While Taking Novo’s Wegovy - BioSpace
BioSpacearrow_outwardNovo Nordisk launches Wegovy in India as weight-loss market heats up - Nikkei Asia
Nikkei Asiaarrow_outwardWegovy-maker Novo Nordisk abruptly ends partnership with Hims & Hers - Morning Brew
Morning Brewarrow_outwardNovo Nordisk Launches Weight-Loss Drug 'Wegovy' In India - NDTV
NDTVarrow_outwardNovo Nordisk launches blockbuster weight loss drug Wegovy in India - CNBC TV18
CNBC TV18arrow_outwardWegovy, widely popular weight-loss drug, launched in India: Price, dosage - India Today
India Todayarrow_outwardHims & Hers stock plunges after Novo Nordisk ends its brief partnership - Business Insider
Business Insiderarrow_outwardNovo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds - ABC News - Breaking News, Latest News and Videos
ABC News - Breaking News, Latest News and Videosarrow_outwardWegovy Partnership Unravels as Novo Nordisk, Hims & Hers Trade Accusations - Athletech News
Athletech Newsarrow_outwardHims Crashes After Novo Unexpectedly Yanks Collaboration Deal - Investor's Business Daily
Investor's Business Dailyarrow_outwardWegovy Fallout: How Novo’s Exit Hits Your Wallet and Waistline - Money Talks News
Money Talks Newsarrow_outwardNovo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices - CBS News
CBS Newsarrow_outwardHims & Hers stock plummets after Novo Nordisk ends partnership over ‘knockoff’ Wegovy - Fast Company
Fast Companyarrow_outwardNovo Nordisk ends partnership with Hims & Hers over Wegovy copycats - The Hill
The Hillarrow_outwardPopular weight loss drugs like Wegovy, Zepbound remain unaffordable for many in need - News Channel 6 | Wichita Falls, TX
News Channel 6 | Wichita Falls, TXarrow_outwardNovo Nordisk halts Wegovy deal with Hims & Hers, triggering 31% stock drop - USA Today
USA Todayarrow_outwardRecon: Lilly’s bimagrumab plus Novo’s Wegovy prove potent for weight management; MHRA adds second AI airlock - Regulatory Affairs Professionals Society | RAPS
Regulatory Affairs Professionals Society | RAPSarrow_outwardNovo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs - Financial Times
Financial Timesarrow_outwardNovo abruptly ends obesity drug deal with Hims - BioPharma Dive
BioPharma Divearrow_outwardEli Lilly drug bimagrumab saves muscle mass when added to Novo's Wegovy - Seeking Alpha
Seeking Alphaarrow_outwardHims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company. - MarketWatch
MarketWatcharrow_outwardNovo ends partnership with Hims & Hers over compounding concerns - Axios
Axiosarrow_outwardEli Lilly drug preserves lean mass in patients losing weight on Wegovy - STAT
STATarrow_outwardNovo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34% - CNBC
CNBCarrow_outwardNew weight-loss drug is ‘better than Wegovy’ — and comes in a pill - The Times
The Timesarrow_outward4 FDA-Approved Weight Loss Medications, According To Experts - Forbes
Forbesarrow_outwardNovo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee - Fortune
Fortunearrow_outwardWeight-loss injections: How do drugs like Wegovy and Mounjaro work? - BBC
BBCarrow_outward‘It’s a new era’: Are weight-loss drugs like Ozempic, Wegovy safe? - NewsNation
NewsNationarrow_outwardAs costs of weight loss drugs like Wegovy and Zepbound go down, how low can prices go? - NBC News
NBC Newsarrow_outwardZepbound outduels Wegovy in weight-loss clinical trial - Cornell Chronicle
Cornell Chroniclearrow_outwardWhy Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug - The New York Times
The New York Timesarrow_outwardZepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs - AP News
AP Newsarrow_outwardZepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine - Eli Lilly and Company
Eli Lilly and Companyarrow_outwardOnce-Weekly Semaglutide in Adults with Overweight or Obesity - The New England Journal of Medicine
The New England Journal of Medicinearrow_outward
Wegovy close
- 2025-06-28 20:00 event
- 64 sourceslanguage
- 200+ ads_click
- 2 months ago schedule